Publications
5674 Results
- Journal / Conference
- J Clin Oncol 30 (suppl; abstr 7005);American Society of Clinical Oncology 2012 Annual Mtg (June 1-5, 2012, Chicago, IL), oral presentation;
- Year
- 2012
- Research Committee(s)
- Lung
- Study Number(s)
- S0802
SWOG 0802: A Randomized Phase II Trial of Weekly Topotecan With and Without AVE0005 (Aflibercept) in Patients with Platinum-treated Extensive Stage Small Cell Lung Cancer (E-SCLC)
- Journal / Conference
- J Clin Oncol 30 (suppl; abstr 8521); American Society of Clinical Oncology 2012 Annual Mtg (June 1-5, 2012, Chicago, IL), poster discussion;
- Year
- 2012
- Research Committee(s)
- Melanoma
- Study Number(s)
- S0826
SWOG S0826: A Phase II Trial of SCH 727965 (NSC 747135) in Patients with Stage IV Melanoma
- Journal / Conference
- J Clin Oncol 30 (suppl; abstr 5015); American Society of Clinical Oncology 2012 Annual Mtg (June 1-5, 2012, Chicago, IL), poster discussion;
- Year
- 2012
- Research Committee(s)
- Gynecologic
- Study Number(s)
- S0904
Randomized phase II study of docetaxel plus vandetanib (V+D) versus docetaxel followed by vandetanib (D --> V) in patients with persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma (OC): SWOG S0904
- Journal / Conference
- J Clin Oncol 30 (suppl; abstr 8525); American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), poster discussion;
- Year
- 2012
- Research Committee(s)
- Melanoma
- Study Number(s)
- S0933
Phase II trial of RO4929097 Notch Gamma-Secretase Inhibitor in Metastatic Melanoma: SWOG S0933 (ClinicalTrials.gov Identifier: NCT01120275)
- Journal / Conference
- J Clin Oncol 30 (suppl; abstr 4113); American Society of Clinical Oncology 2012 Annual Mtg (June 1-5, 2012, Chicago, IL), poster presenetation;
- Year
- 2012
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0941
SWOG 0941: A phase II study of Sorafenib and Erlotinib in patients (pts) with advanced gallbladder cancer or cholangiocarcinoma
- Journal / Conference
- J Clin Oncol 30 (suppl; abstr 4010); American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), poster discussion;
- Year
- 2012
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)
Assessment of HER2 Gene Amplification in Adenocarcinomas of the Stomach or Gastroesophageal Junction in the INT-0116/SWOG9008 Clinical Trial
- Journal / Conference
- J Clin Oncol 30 (suppl; abstr 4); American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), oral, plenary session;
- Year
- 2012
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-9346
Intermittent (IAD) vs Continuous Androgen Deprivation (CAD) in Hormone Sensitive Metastatic Prostate Cancer (HSM1PC) Patients (pts): Results of S9346 (INT-0162) an International Phase III trial
- Journal / Conference
- Journal of Clinical Oncology 30 (suppl; abstr 4571); American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), poster discussion;
- Year
- 2012
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-9346
Preliminary quality of life outcomes for SWOG-9346: intermittent androgen deprivation in patients with hormone sensitive metastatic prostate cancer (HSM1PC), phase III
- Journal / Conference
- J Clin Oncol 30 (suppl; abstr 2008b); American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), oral;
- Year
- 2012
- Research Committee(s)
- Brain
Chemotherapy plus Radiotherapy (CT-RT) vs. RT Alone for Patients with Anaplastic Oligodendroglioma: Long Term Results of the RTOG 9402 Phase III Study
- Journal / Conference
- World Journal of Urology 30(2):189-194
- Year
- 2012
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID22238120
- PMC
- PMC n/a
- Study Number(s)
- S0000